SCOTTISH researchers are leading an international initiative to develop affordable technologies for tuberculosis testing, which could help millions of patients who are living in poverty or remote settings.

There are more than 10 million new cases of TB every year, and the €4.5 million (£4.1m) project, known as Accurate, Rapid, Robust and Economical diagnostic technologies for Tuberculosis (ARREST-TB) aims to offer an affordable, accurate diagnosis in poor and hard to reach areas.

The team will develop diagnostic tests that require low implementation and running costs and minimal training and expertise.

Doctors will use the technology to interpret test results, log location details of patients and transmit data for reporting cases.

Existing TB tests need skilled personnel, cost significant amounts and require centralised facilities which are difficult to set up and maintain in remote locations.

The project is led by Edinburgh University’s School of Chemistry alongside Heriot-Watt University, the University of Padova, the Central Tuberculosis Research Institute in Moscow, and India’s National Institute for Research in Tuberculosis.

Also involved are Spain’s DestiNA Genomica and Genetic Analysis Strategies, India’s Shanmukha Innovations, and Optoi, from Italy.

Dr Seshasailam Venkateswaran from the University of Edinburgh’s School of Chemistry, who is leading the project, said: “Our diagnostics will enable precise treatments and limit disease propagation. The project is driven by a practical need to achieve diagnosis of TB and drug resistance and a seamless collection of data at low costs with minimal training and expertise.

“Our diagnostics will enable precise treatments and limit disease propagation.”